River Global Investors LLP Trims Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

River Global Investors LLP reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 17,954 shares of the company’s stock after selling 1,593 shares during the period. River Global Investors LLP’s holdings in GE HealthCare Technologies were worth $1,388,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. First Command Advisory Services Inc. grew its holdings in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after buying an additional 369 shares during the last quarter. OFI Invest Asset Management purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. ORG Partners LLC increased its holdings in shares of GE HealthCare Technologies by 174.2% in the third quarter. ORG Partners LLC now owns 425 shares of the company’s stock valued at $29,000 after purchasing an additional 270 shares during the period. Fortitude Family Office LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $29,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $30,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock traded up $1.64 during trading hours on Friday, hitting $79.47. The stock had a trading volume of 2,722,865 shares, compared to its average volume of 3,070,492. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The stock has a market capitalization of $36.27 billion, a price-to-earnings ratio of 23.24, a PEG ratio of 2.86 and a beta of 1.26. The stock’s fifty day moving average is $88.25 and its two-hundred day moving average is $79.07. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting analysts’ consensus estimates of $0.90. The firm had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The firm’s revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.85 EPS. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of analyst reports. Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Argus lifted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Citigroup increased their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, Mizuho cut their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $95.00.

Insider Buying and Selling

In related news, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the transaction, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.